AI Portfolio Summary
In 2025 Q4, Bleichroeder LP maintained a portfolio of 77 distinct positions. The most significant new addition to the portfolio was KAZIA THERAPEUTICS L, which now represents 0.48% of the total fund value. They heavily accumulated shares in COMPOSECURE INC, increasing their position by 1.4%. The fund also reduced its exposure to STRUCTURE THERAPEUTI by 50.0%.
Total Positions
77
Quarter
2025 Q4
Top Holding
GLD (33.1%)
Top 10 Concentration
82.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 77
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GLD
SPDR GOLD TR
|
ETF | 33.12% | 32.92% |
#1
Prev: #1
|
7.0 | no change | no change |
P
S
|
475,000 | $188,247,250 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPO
COMPOSECURE INC
|
Industrials | 13.48% | 15.91% |
#2
Prev: #2
|
6.0 | 55,210 | 1.4% |
P
S
|
3,974,676 | $76,631,747 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RHLD
RESOLUTE HLDGS ...
|
Industrials | 11.62% | 4.52% |
#3
2
Prev: #5
|
5.5 | -1,569 | -0.5% |
P
S
|
319,844 | $66,025,397 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LIN
LINDE PLC
|
Basic Materials | 5.64% | 7.60% |
#4
1
Prev: #3
|
3.3 | -7,000 | -8.5% |
P
S
|
75,114 | $32,027,858 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDXH
MDXHEALTH SA
|
Healthcare | 4.63% | 6.69% |
#5
1
Prev: #4
|
3.4 | no change | no change |
P
S
|
7,378,333 | $26,340,649 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPY
SPDR S&P 500 ET...
|
ETF | 3.91% | 4.23% |
#6
Prev: #6
|
2.6 | no change | no change |
P
S
|
32,570 | $22,210,134 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DUOT
DUOS TECHNOLOGI...
|
Technology | 3.22% | 2.34% |
#7
1
Prev: #8
|
2.3 | no change | no change |
P
S
|
1,627,806 | $18,312,818 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BX
BLACKSTONE INC
|
Financial Services | 2.46% | 3.02% |
#8
1
Prev: #7
|
2.0 | no change | no change |
P
S
|
90,750 | $13,988,205 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IDN
INTELLICHECK IN...
|
Technology | 2.44% | 2.10% |
#9
Prev: #9
|
2.0 | no change | no change |
P
S
|
2,073,583 | $13,851,534 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INVE
IDENTIV INC
|
Industrials | 1.95% | 1.94% |
#10
Prev: #10
|
1.8 | no change | no change |
P
S
|
2,884,495 | $11,076,461 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPGI
S&P GLOBAL INC
|
Financial Services | 1.84% | 1.90% |
#11
Prev: #11
|
1.7 | no change | no change |
P
S
|
20,000 | $10,451,800 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DTIL
PRECISION BIOSC...
|
Healthcare | 1.22% | 1.16% |
#12
1
Prev: #13
|
3.5 | 587,500 | 54.7% |
P
S
|
1,662,500 | $6,916,000 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 1.02% | 0.71% |
#13
5
Prev: #18
|
2.9 | 60,000 | 23.4% |
P
S
|
316,515 | $5,782,729 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 0.92% | 0.35% |
#14
15
Prev: #29
|
2.4 | 150,000 | 17.6% |
P
S
|
1,000,000 | $5,230,000 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OWLT
OWLET INC
|
Healthcare | 0.88% | 0.45% |
#15
12
Prev: #27
|
2.4 | 40,000 | 14.8% |
P
S
|
310,000 | $5,018,900 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JPM
JPMORGAN CHASE ...
|
Financial Services | 0.85% | 0.92% |
#16
1
Prev: #17
|
1.3 | no change | no change |
P
S
|
15,000 | $4,833,300 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LIQT
LIQTECH INTL IN...
|
Industrials | 0.82% | 1.63% |
#17
5
Prev: #12
|
1.3 | no change | no change |
P
S
|
3,182,239 | $4,646,069 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PROK
PROKIDNEY CORP
|
Healthcare | 0.79% | 0.94% |
#18
3
Prev: #15
|
1.3 | no change | no change |
P
S
|
2,000,000 | $4,480,000 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BRFH
BARFRESH FOOD G...
|
Consumer Defensive | 0.72% | 0.94% |
#19
3
Prev: #16
|
1.3 | no change | no change |
P
S
|
1,390,758 | $4,074,921 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WELL
WELLTOWER INC
|
Real Estate | 0.65% | 0.69% |
#20
1
Prev: #19
|
1.3 | no change | no change |
P
S
|
20,000 | $3,712,200 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FLNT
FLUENT INC
|
Communication Services | 0.60% | 0.62% |
#21
Prev: #21
|
1.2 | no change | no change |
P
S
|
1,428,571 | $3,428,570 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GNLX
GENELUX CORPORA...
|
Healthcare | 0.55% | 0.58% |
#22
Prev: #22
|
1.2 | no change | no change |
P
S
|
714,000 | $3,113,040 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DMAC
DIAMEDICA THERA...
|
Healthcare | 0.54% | 0.51% |
#23
2
Prev: #25
|
1.2 | no change | no change |
P
S
|
382,317 | $3,043,243 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NMTC
NEUROONE MED TE...
|
Healthcare | 0.53% | 0.69% |
#24
4
Prev: #20
|
1.2 | no change | no change |
P
S
|
4,000,000 | $3,032,000 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TV
GRUPO TELEVISA ...
|
Communication Services | 0.53% | 0.54% |
#25
1
Prev: #24
|
1.2 | no change | no change |
P
S
|
1,030,000 | $2,997,300 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QQQ
INVESCO QQQ TR
|
ETF | 0.50% | 0.54% |
#26
3
Prev: #23
|
1.2 | no change | no change |
P
S
|
4,640 | $2,850,398 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KZIA
KAZIA THERAPEUT...
|
Healthcare | 0.48% | — |
#27
Prev: #—
|
3.7 | 400,000 | no change |
NEW
|
400,000 | $2,756,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CUE
CUE BIOPHARMA I...
|
Healthcare | 0.37% | 0.96% |
#28
14
Prev: #14
|
1.1 | no change | no change |
P
S
|
6,819,164 | $2,082,573 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PROF
PROFOUND MED CO...
|
Healthcare | 0.35% | 0.17% |
#29
8
Prev: #37
|
2.6 | 71,420 | 39.0% |
P
S
|
254,753 | $2,004,906 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VENU
VENU HLDG CORP
|
Consumer Cyclical | 0.30% | 0.50% |
#30
4
Prev: #26
|
1.1 | no change | no change |
P
S
|
200,000 | $1,684,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRD
OPUS GENETICS I...
|
Healthcare | 0.26% | 0.24% |
#31
2
Prev: #33
|
1.1 | no change | no change |
P
S
|
736,842 | $1,481,052 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PXLW
PIXELWORKS INC
|
Technology | 0.22% | — |
#32
Prev: #—
|
3.6 | 201,015 | no change |
NEW
|
201,015 | $1,278,455 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLYVK
LIBERTY LIVE HO...
|
Communication Services | 0.21% | 0.26% |
#33
2
Prev: #31
|
1.1 | no change | no change |
P
S
|
13,802 | $1,174,827 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRIS
CURIS INC
|
Healthcare | 0.20% | 0.37% |
#34
6
Prev: #28
|
1.1 | no change | no change |
P
S
|
1,135,662 | $1,121,012 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RTX
RTX CORPORATION
|
Industrials | 0.19% | 0.20% |
#35
1
Prev: #34
|
1.1 | no change | no change |
P
S
|
6,000 | $1,100,400 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MODD
MODULAR MED INC
|
Healthcare | 0.18% | 0.27% |
#36
6
Prev: #30
|
2.6 | 845,000 | 41.9% |
P
S
|
2,859,581 | $1,041,173 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TLPH
TALPHERA INC
|
Healthcare | 0.18% | 0.15% |
#37
1
Prev: #38
|
1.1 | no change | no change |
P
S
|
881,166 | $1,004,529 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
POCI
PRECISION OPTIC...
|
Healthcare | 0.16% | 0.19% |
#38
2
Prev: #36
|
1.1 | no change | no change |
P
S
|
220,230 | $921,663 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.12% | 0.11% |
#39
6
Prev: #45
|
0.0 | -10,000 | -50.0% |
P
S
|
10,000 | $695,500 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ICCC
IMMUCELL CORP
|
Healthcare | 0.11% | 0.12% |
#40
2
Prev: #42
|
1.0 | no change | no change |
P
S
|
101,594 | $624,803 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LWLG
LIGHTWAVE LOGIC...
|
Basic Materials | 0.09% | — |
#41
Prev: #—
|
3.5 | 166,000 | no change |
NEW
|
166,000 | $537,840 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNXT
RENOVORX INC
|
Healthcare | 0.09% | 0.13% |
#42
2
Prev: #40
|
2.0 | 61,379 | 11.4% |
P
S
|
600,000 | $504,060 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLYVA
LIBERTY LIVE HO...
|
Communication Services | 0.09% | 0.11% |
#43
Prev: #43
|
1.0 | no change | no change |
P
S
|
6,047 | $501,719 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LHX
L3HARRIS TECHNO...
|
Industrials | 0.08% | 0.10% |
#44
4
Prev: #48
|
1.0 | no change | no change |
P
S
|
1,600 | $469,712 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHYS
SPROTT ASSET MA...
|
Unknown | 0.07% | 0.07% |
#45
5
Prev: #50
|
1.0 | no change | no change |
P
S
|
12,540 | $414,071 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IPWR
IDEAL PWR INC
|
Technology | 0.07% | 0.13% |
#46
5
Prev: #41
|
1.0 | no change | no change |
P
S
|
133,000 | $410,970 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AZ
A2Z CUST2MATE S...
|
Technology | 0.07% | 0.10% |
#47
Prev: #47
|
1.0 | no change | no change |
P
S
|
62,000 | $403,620 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OPFI/WS
OPPFI INC
|
Unknown | 0.07% | 0.11% |
#48
4
Prev: #44
|
1.0 | no change | no change |
P
S
|
250,000 | $382,500 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MSAI
MULTISENSOR AI ...
|
Technology | 0.06% | 0.09% |
#49
Prev: #49
|
3.0 | 522,493 | 74.6% |
P
S
|
1,222,493 | $352,078 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CARR
CARRIER GLOBAL ...
|
Industrials | 0.06% | 0.07% |
#50
1
Prev: #51
|
1.0 | no change | no change |
P
S
|
6,000 | $317,040 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-50 of 77 holdings